Menu
| Description | KMRC-20 is a human renal cell carcinoma cell line established from kidney tumor tissue. The cell line exhibits an epithelial-like morphology and grows as an adherent monolayer in culture. KMRC-20 has an unlimited lifespan in vitro and serves as a valuable model for renal cancer research, particularly studies involving clear cell renal cell carcinoma (ccRCC), tumor biology, cancer signaling pathways, and anticancer drug discovery. |
| Product Name | KMRC-20 Cell Line |
| Cat.No | RWT-1249 |
| Product type | Human renal carcinoma cell line |
| Product category | Tumor Cell Lines |
| Size | 1*10^6 cells/vial |
| Description | KMRC-20 is a human renal cell carcinoma cell line established from kidney tumor tissue. The cell line exhibits an epithelial-like morphology and grows as an adherent monolayer in culture. KMRC-20 has an unlimited lifespan in vitro and serves as a valuable model for renal cancer research, particularly studies involving clear cell renal cell carcinoma (ccRCC), tumor biology, cancer signaling pathways, and anticancer drug discovery. |
| Tissue | Kidney |
| Species | Human |
| Disease | Renal cell carcinoma |
| Biosafety Level | BSL 1 |
| Morphology | Epithelial-like, adherent |
| Passage Ratio | 1:2~1:3 |
| Culture Method | DMEM+10% FBS+1% P/S |
| Quality Control | STR authenticated & mycoplasma free; ≥90% viability on delivery |
| Shipping | Dry ice |
| Storage | Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use. |
| Warranty | KMRC20 Cell Line is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA. |
| Disclaimers | For Research Use Only |
| Applications | KMRC-20 is an established human clear cell renal cell carcinoma cell line used for renal cancer biology research, cancer signaling pathway analysis, tumor progression and metastasis studies, biomarker discovery, and therapeutic target validation. The cell line is also suitable for anticancer drug screening, evaluation of treatment resistance mechanisms, immunotherapy-related studies, and genetic engineering applications including CRISPR/Cas9-mediated genome editing. |
If use of this product results in a scientific publication, it should be cited in the publication as: KMRC-20 Cell Line (Runtogen RWT-1249).
Inquire the KMRC-20 Cell Line by filling out the form below. We’ll get back to you within 24 hours with a quote.
Inquire the KMRC-20 Cell Line by filling out the form below. We’ll get back to you within 24 hours with a quote.
